tirzepatide + levocarnitine Troubling Findings in Study of GLP-1 Compounders Tirzepatide + L-Carnitine - IV

Lipid profile insights: Used in lab settings to explore triglyceride and cholesterol regulation

In addition to their primary purpose of treating type 2 diabetes, GLP-1 (glucagon-like peptide-1) agonist drugs are also licensed for use in the treatment of obesity

The support available: Ongoing clinical care, nutritional guidance and Health Coaching can make a meaningful difference to long-term success

Investigation 79 (2), 616619

They mimic a natural hormone that helps control appetite, slow digestion, and reduce blood sugar spikes after meals, which supports gradual reductions in body weight over time

Of note, the Endocrine Society guidelines on hypoglycemia state that an oral glucose tolerance test should never be used to document postprandial hypoglycemia